Research ArticleClinical Studies
Febuxostat as a Prophylaxis for Tumor Lysis Syndrome in Children with Hematological Malignancies
KENJI KISHIMOTO, RYOJI KOBAYASHI, DAIKI HORI, HIROZUMI SANO, DAISUKE SUZUKI and KUNIHIKO KOBAYASHI
Anticancer Research October 2017, 37 (10) 5845-5849;
KENJI KISHIMOTO
Department of Hematology/Oncology for Children and Adolescents, Sapporo Hokuyu Hospital, Sapporo, Japan
RYOJI KOBAYASHI
Department of Hematology/Oncology for Children and Adolescents, Sapporo Hokuyu Hospital, Sapporo, Japan
DAIKI HORI
Department of Hematology/Oncology for Children and Adolescents, Sapporo Hokuyu Hospital, Sapporo, Japan
HIROZUMI SANO
Department of Hematology/Oncology for Children and Adolescents, Sapporo Hokuyu Hospital, Sapporo, Japan
DAISUKE SUZUKI
Department of Hematology/Oncology for Children and Adolescents, Sapporo Hokuyu Hospital, Sapporo, Japan
KUNIHIKO KOBAYASHI
Department of Hematology/Oncology for Children and Adolescents, Sapporo Hokuyu Hospital, Sapporo, Japan
In this issue
Anticancer Research
Vol. 37, Issue 10
October 2017
Febuxostat as a Prophylaxis for Tumor Lysis Syndrome in Children with Hematological Malignancies
KENJI KISHIMOTO, RYOJI KOBAYASHI, DAIKI HORI, HIROZUMI SANO, DAISUKE SUZUKI, KUNIHIKO KOBAYASHI
Anticancer Research Oct 2017, 37 (10) 5845-5849;
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.